EMJ Podcast: Insights For Healthcare Professionals

Featuring leading cardiology experts, this podcast episode navigates atherosclerotic cardiovascular disease (ASCVD), including plaque morphology, residual risk, secondary treatment options, and guidelines from the National Institute for Health and Care Excellence (NICE). They also detail how these different treatment options work, and conclude the episode by sharing relevant patient case studies that reflect the themes discussed.   Lale Tokgözoğlu, Professor of Cardiology, Hacettepe University, Ankara, Turkey; and Pierre Sabouret, Heart Institute, ACTION Study Group-CHU Pitié-Salpêtrière University Hospital, Paris, France, join EMJ to share their expert insights on this pertinent topic.   Following the recording of this podcast the European Society of Cardiology (ESC) 2023 Guidelines have been updated. Please refer to your local guidelines and relevant prescribing information for the most up-to-date information.   Disclaimer: This podcast is sponsored by an educational grant by Amarin. The speakers opinion is entirely their own and did not receive an honorarium for their part.

This week, Jennifer Dixon joins Jonathan to share the mission of The Health Foundation, which she is Chief Executive Office of. The pair discuss the resource allocation formula that was created, taking into account the needs of the population, as well as the future of national strategy in health and healthcare. They further explore underfunding in the National Health Service (NHS), and the importance of investing in community care.  

Use the following timestamps to navigate the content in this episode: 

(00:00)-Introduction 

(02:05)-Dixon’s route into medicine  

(03:57)-The Health Foundation 

(08:00)-Future strategies for national healthcare systems  

(14:05)-’The thermostat is set too cold’, Europe versus the USA  

(18:32)-Dixon’s publications  

(24:40)-Telehealth and artificial intelligence as tools in healthcare  

(26:50)-’Money is too tight to mention’ and the NHS as a ‘political hot potato’ 

(32:24)-The highs and lows with global healthcare provision  

(24:40)-Future services 

(37:46)-Use of social media and Dixon’s ‘a-ha!’ moments  

(42:08)-Dixon’s three wishes 

Discussing the burden of hypertrophic cardiomyopathy (HCM), expert in this field Pablo Garcia-Pavia, Puerta de Hierro Majadahonda University Hospital, Madrid, Spain, sheds light on the diagnosis and treatment of HCM. Further discussion centres around myosin inhibitor drugs, specifically their mechanism of action, associated advantages and limitations, and their relevance to HCM subtypes are outlined. Relevant studies presented at the European Society of Cardiology (ESC) Congress 2023, as well as ongoing clinical trials and research initiatives focused on myosin inhibitors and HCM treatment, are also summarised.   It'll also highlight the latest ESC Guidelines and how they play a crucial role in shaping clinical practice, before looking ahead to the most promising advancements in the field of HCM treatment.   This medical education podcast was sponsored by Myokardia and Bristol Myers Squibb.

This podcast we will focus on one particular treatment, mexiletine and to understand how the medication’s cardiac side-effects could affect how it is prescribed. This podcast aims to help neurologists to understand the cardiologist’s perspective, by assessing the safety profile and data on mexiletine and the best approach for treatment initiation and maintenance.
This podcast was sponsored by Lupin Atlantis Holdings SA

In this episode, Jonathan is once again joined by Vikram Talaulikar, Associate Specialist in reproductive medicine at the University College London Hospitals (UCLH) NHS Foundation Trust, UK, to explore different treatment options for menopause, including lifestyle changes, alternative medicine, hormone replacement therapy, and non-hormonal treatments. They further dive into the symptoms, diagnosis, and treatment of polycystic ovary syndrome, and implications of oestrogen deficiency.

 

Use the following timestamps to navigate the topics in this episode:

(00:00)-Introduction

(00:43)-Treatments for menopause: benefits and side effects

(11:30)-Reasons for, and impact of, perimenopause

(16:18)-Polycystic ovary syndrome 101

(22:29)-Oestrogen deficiency and its implications

(25:53)-Three wishes for the future of healthcare

In the first episode, Solomon Tesfaye and Ollie Binns-Hall explore the pressing issue of the diabetes epidemic and its most prevalent microvascular complication: neuropathy. They discuss the identification and characterisation of these critical aspects of diabetes and explore the causes, symptoms, and challenges of diagnosing neuropathy within the broader context of diabetes.

 

This content has been supported by Viatris

In the second episode, Solomon Tesfaye and Ollie Binns-Hall unravel the intricate relationship between diabetes and pain. They focus on the current approaches to identifying diabetic peripheral neuropathy and explore the risk factors, and current detection and management approaches, identifying the challenges associated with managing this multifaceted condition.

 

This content has been supported by Viatris

This podcast, featuring Dr. João Neves, a pediatrician and Associate Professor at Nova Medical School in Lisbon, Portugal, who has a Ph.D. in immunology, also Head of the Paediatrics Department at the Hospital da Luz in Lisbon, will delve into the intricacies of RSV, exploring its structure, transmission, symptoms, its impact on both healthy and at-risk infants, the epidemiology surrounding it, its seasonality, and its relationship with the ongoing COVID pandemic.

This podcast was organized and funded by Sanofi. The statements are reflecting the opinion of the expert interviewed based on his clinical experience

MAT-GLB-2301791

Vikram Talaulikar, Associate Specialist in reproductive medicine at the University College London Hospitals (UCLH) NHS Foundation Trust, UK, joins Jonathan to discuss menopause symptoms, how these can differ depending on ethnicity, how they vary over time, and possible treatments.

Use the following timestamps to navigate the topics in this episode:

(00:00)-Introduction

(02:38)-Vikram’s inspiration in pursuing his career

(04:00)-Explaining perimenopause and menopause

(08:21)-Ethnic differences in experience of menopause, and areas where further research is needed

(13:22)-Post-menopause: the most productive years of a woman’s life?

(20:15)-What GPs and specialists need to understand about the field

In this first podcast, Kevin Boehnke and Dan Clauw delve into the patient’s perspective regarding the burden of fibromyalgia. They explore the impact of fibromyalgia on a person’s life, with Kevin sharing his personal experiences. Both experts also evaluate the significance of non-pharmaceutical treatment options for managing this condition.

Speakers

Dr Kevin Boehnke

Research Assistant Professor, Department of Anaesthesiology and the Chronic Pain and Fatigue Research Centre, University of Michigan Medical School, Ann Arbor, USA

Dr Boehnke received his doctorate from the University of Michigan School of Public Health in Environmental Health Sciences in 2017. Dr Boehnke’s current research focuses on therapeutic applications of cannabis and psychedelics where his goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalisation. He is also a yoga instructor and he himself lives with fibromyalgia.

Professor Daniel Clauw

Professor of Anasthesiology, Internal Medicine of Rheumatology and Psychiatry, and the Chronic Pain and Fatigue Research Centre, University of Michigan Medical School, Ann Arbor, USA

Professor Clauw serves as Director of the Chronic Pain and Fatigue Research Centre at the University of Michigan, USA and co-directs the Research Development Core and Pre-Doctoral Programs. His research is committed to clinical care and research into the central nervous system. He is an international expert in chronic pain disorders, such as fibromyalgia, where he incorporates a multitude of methods ranging from patient-reported outcomes to functional and chemical neuroimaging, and phenotyping, and as such, has been critical in helping elucidate the importance of the central nervous system in chronic pain conditions.

This content has been supported by Viatris